TCL Archive Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies June 25, 2010
TCL Archive Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study May 30, 2008